Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2019 Financial Results and Provide Corporate Update on February 26
Conference Call & Webcast Information
Dial-in: (877) 643-7155 (
Conference ID: 8286947
Please join the conference call at least 10 minutes early to register. You can access the live webcast under the investor relations section of Arena's website. A replay of the conference call will be archived for 30 days after the call.
It is the breadth and depth of our portfolio, prioritization of drug development to meet unmet patient needs, strong financial health and growing, bold-thinking world-class team that gives Arena the ingredients and passion to build a sustainable, vibrant next-generation pharmaceutical company.
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's upcoming conference call and live webcast with the investment community and Arena's position, drive, portfolio, prioritization, financial position, team, and building of the company. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the
Executive Vice President and
Chief Financial Officer
View original content to download multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-release-fourth-quarter--full-year-2019-financial-results-and-provide-corporate-update-on-february-26-301007890.html